These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9062714)

  • 21. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent.
    Fountaine H; Harnish P; Andrew E; Grynne B
    Acad Radiol; 1996 Sep; 3 Suppl 3():S475-84. PubMed ID: 8883524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG; Stenport G; Andersson M
    Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Limitless" contrast for coronary angiography?
    Brinker JA
    Cathet Cardiovasc Diagn; 1997 Mar; 40(3):247-8. PubMed ID: 9062715
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting cardiotoxicity propensity of the novel iodinated contrast medium GE-145: Ventricular fibrillation during left coronary arteriography in pigs.
    Chai CM; Rasmussen H; Eriksen M; Hvoslef AM; Evans P; Newton BB; Videm S
    Acta Radiol; 2010 Nov; 51(9):1007-13. PubMed ID: 20799918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary arteriography with iotrolan 280, a blood-isotonic, nonionic, dimeric contrast medium: preliminary clinical results.
    Schräder R; Kaltenbach M; Kober G
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():77-80. PubMed ID: 2568813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of proximal fixation to renal dysfunction in patients undergoing endovascular aneurysm repair.
    Mehta M; Cayne N; Veith FJ; Darling RC; Roddy SP; Paty PS; Ozsvath KJ; Kreienberg PB; Chang BB; Shah DM
    J Cardiovasc Surg (Torino); 2004 Aug; 45(4):367-74. PubMed ID: 15365517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
    Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
    Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioangiography and the hemodynamic effects of iodixanol.
    Klow NE; Jacobsen EA; Refsum H
    Acta Radiol Suppl; 1995; 399():93-9. PubMed ID: 8610534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II.
    Bolstad B; Borch KW; Grynne BH; Lundby B; Nossen JO; Kloster YF; Kristoffersen DT; Andrew E
    Invest Radiol; 1991 Nov; 26 Suppl 1():S201-4; discussion S208. PubMed ID: 1808130
    [No Abstract]   [Full Text] [Related]  

  • 40. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.